GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Acotec Scientific Holdings Ltd (HKSE:06669) » Definitions » Beneish M-Score

Acotec Scientific Holdings (HKSE:06669) Beneish M-Score : -2.48 (As of May. 25, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Acotec Scientific Holdings Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.48 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Acotec Scientific Holdings's Beneish M-Score or its related term are showing as below:

HKSE:06669' s Beneish M-Score Range Over the Past 10 Years
Min: -2.48   Med: -2.36   Max: 0.72
Current: -2.48

During the past 5 years, the highest Beneish M-Score of Acotec Scientific Holdings was 0.72. The lowest was -2.48. And the median was -2.36.


Acotec Scientific Holdings Beneish M-Score Historical Data

The historical data trend for Acotec Scientific Holdings's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acotec Scientific Holdings Beneish M-Score Chart

Acotec Scientific Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
- - -2.36 0.72 -2.48

Acotec Scientific Holdings Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only -2.36 - 0.72 - -2.48

Competitive Comparison of Acotec Scientific Holdings's Beneish M-Score

For the Medical Devices subindustry, Acotec Scientific Holdings's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Acotec Scientific Holdings's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Acotec Scientific Holdings's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Acotec Scientific Holdings's Beneish M-Score falls into.



Acotec Scientific Holdings Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Acotec Scientific Holdings for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9601+0.528 * 1.0676+0.404 * 1.1913+0.892 * 1.1734+0.115 * 1.2064
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.943+4.679 * 0.016989-0.327 * 2.0506
=-2.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was HK$166.5 Mil.
Revenue was HK$518.3 Mil.
Gross Profit was HK$412.8 Mil.
Total Current Assets was HK$1,324.7 Mil.
Total Assets was HK$1,762.1 Mil.
Property, Plant and Equipment(Net PPE) was HK$386.2 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$50.6 Mil.
Selling, General, & Admin. Expense(SGA) was HK$198.3 Mil.
Total Current Liabilities was HK$127.1 Mil.
Long-Term Debt & Capital Lease Obligation was HK$216.6 Mil.
Net Income was HK$15.8 Mil.
Gross Profit was HK$0.0 Mil.
Cash Flow from Operations was HK$-14.1 Mil.
Total Receivables was HK$147.8 Mil.
Revenue was HK$441.7 Mil.
Gross Profit was HK$375.6 Mil.
Total Current Assets was HK$1,403.1 Mil.
Total Assets was HK$1,575.2 Mil.
Property, Plant and Equipment(Net PPE) was HK$133.6 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$21.7 Mil.
Selling, General, & Admin. Expense(SGA) was HK$179.2 Mil.
Total Current Liabilities was HK$110.2 Mil.
Long-Term Debt & Capital Lease Obligation was HK$39.7 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(166.486 / 518.285) / (147.778 / 441.711)
=0.321225 / 0.334558
=0.9601

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(375.61 / 441.711) / (412.809 / 518.285)
=0.850352 / 0.79649
=1.0676

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1324.702 + 386.178) / 1762.14) / (1 - (1403.083 + 133.629) / 1575.176)
=0.02909 / 0.024419
=1.1913

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=518.285 / 441.711
=1.1734

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(21.709 / (21.709 + 133.629)) / (50.596 / (50.596 + 386.178))
=0.139753 / 0.11584
=1.2064

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(198.325 / 518.285) / (179.241 / 441.711)
=0.382656 / 0.405788
=0.943

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((216.633 + 127.146) / 1762.14) / ((39.667 + 110.192) / 1575.176)
=0.195092 / 0.095138
=2.0506

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(15.846 - 0 - -14.091) / 1762.14
=0.016989

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Acotec Scientific Holdings has a M-score of -2.48 suggests that the company is unlikely to be a manipulator.


Acotec Scientific Holdings Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Acotec Scientific Holdings's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Acotec Scientific Holdings (HKSE:06669) Business Description

Traded in Other Exchanges
Address
16 North Hongda Road, 4-5th Floor, Building No. 1, Beijing Economic-Technological Development Area, Beijing, CHN
Acotec Scientific Holdings Ltd is a medical device company. The company is focused on providing leave nothing behind treatment solutions for vascular diseases. It has developed a suite of interventional medical devices featuring world- leading technologies, notably in the fields of drug-coated balloons and thrombus aspiration catheters. The company's commercialized product is Semi-compliant PTCA Balloon (YAN) is a product designed for dilation in coronary artery or coronary artery bypass vessels stenosis to improve myocardial perfusion. Geographically, the company operates from Mainland China, Europe and Other countries and regions. Majority of revenue is generated from Mainland China.
Executives
Vistra Trust (singapore) Pte. Limited 2301 Trustee
Nexus Partners Group Limited 2201 Interest of corporation controlled by you
Cosmic Elite Holdings Limited 2101 Beneficial owner
Li Jing 2201 Interest of corporation controlled by you
Cpechina Fund Iii, L.p. 2201 Interest of corporation controlled by you
Cpe Funds Iii Limited 2201 Interest of corporation controlled by you
Ca Medtech Investment Iii Limited 2201 Interest of corporation controlled by you
Ca Medtech Investment Ii Limited 2201 Interest of corporation controlled by you
Ca Medtech Investment (cayman) Limited 2101 Beneficial owner
Cpe Holdings Limited 2201 Interest of corporation controlled by you
Cpe Holdings International Limited 2201 Interest of corporation controlled by you
Cpe Gof Gp Limited 2201 Interest of corporation controlled by you
Cpe Global Opportunities Fund, L.p. 2201 Interest of corporation controlled by you
Boston Scientific Corporation 2201 Interest of corporation controlled by you
Cpechina Fund Iii, L. P.

Acotec Scientific Holdings (HKSE:06669) Headlines

No Headlines